Central America Pharmaceuticals and Healthcare Report Q2 2010

Executive Summary ................................................ 5
SWOT Analysis ........................................................ 6
Central America Pharmaceuticals & Healthcare SWOT .............................................. 6
Pharmaceutical Business Environment Ratings .............................................. 7
Table: Americas Business Environment Ratings, Q210 ................................................ 7
Regulatory Regime .................................................. 8
Guatemala – Ministry of Health (http://www.mspas.gob.gt/) ........................................ 8
Costa Rica – Ministry of Health (http://www.ministeriodesalud.go.cr/) ........................ 8
El Salvador – Ministry of Health (http://www.mspas.gob.sv/) ....................................... 8
Panama – Ministry of Health (http://www.minsa.gob.pa/) ............................................ 8
Nicaragua – Ministry of Health (http://www.minsa.gob.ni/) ......................................... 8
Intellectual Property Regime ................................... 9
Central America Pharmaceutical Market Forecast ......................................... 11
Central America Healthcare Market Forecast ................................................. 14
Central America Pharmaceutical Trade Forecast ........................................... 16
Central America Clinical Trials Sector ................. 18
Macroeconomic Forecast ............................................... 20
Table: Guatemala – Macroeconomic Forecasts ......................................................... 20
Table: Costa Rica – Macroeconomic Forecasts ......................................................... 23
Table: El Salvador – Macroeconomic Forecasts ........................................................ 25
Panama – Macroeconomic Forecasts ............................. 26
Table: Honduras – Macroeconomic Forecasts ........................................................... 28
Table: Nicaragua – Economic Activity ........................... 29
Table: Belize: Economic Activity .................................... 31
Political Risk Analysis .......................................... 32
Industry Developments......................................... 35
Competitive Landscape ........................................ 37
Company Profiles .................................................. 38
Ancalmo Internacional ................................................... 38
Historical D ........................ 38
Donovan Werke .............................................................. 39
Forecasts ............................ 39
Methodology .................................................. 40
How We Generate Our Pharmaceutical Industry Forecasts ............................................ 40
Pharmaceutical Business Environment Ratings Methodology ......................................... 41
Ratings Overview ............................................................ 41
Table: Pharmaceutical Business Environment Indicators .......................................... 42
Weighting ............................ 43
Table: Weighting Of Components ................................... 43
Sources .................................... 43